Liver transplantation, perfusion and oxygen research
The liver-perfusion literature can help define how an oxygen-carrying perfusate is evaluated. Product identity, organ model, temperature and the chosen endpoint remain part of every result.
A human liver model is not a recipient-outcome trial
The historical catalogue includes the use of an acellular oxygen carrier in a human liver model of normothermic machine perfusion. A separate publication addresses donor-liver perfusion without human blood products.
These are relevant source routes for perfusate research. Their titles and models should not be converted into a generic claim of BHOC clinical performance or recipient benefit. The original study and the library’s evidence notes should be read together.
Circuit reliability, metabolism and organ function
The experimental-liver brief compares two methods papers. Nassar’s pig-liver work included a transplant simulation rather than recipient-animal transplantation. Beal’s rat-liver paper examined ex vivo methods and did not include subsequent transplantation.
Neither tested BHOC. They are useful because a perfusate programme must distinguish reliable circuit operation, biochemical injury, energy metabolism and measured organ function. These endpoints should not be treated as interchangeable.
Temperature defines the experimental conditions
Normothermic, hypothermic and cold-to-warm protocols create different operating conditions. The existing Science page treats temperature as a variable to characterize, not an assumption that a carrier has one fixed oxygen-release behaviour across the transplant journey.
Historical HBOC-201 P50 near 40 mmHg is described at 37°C in the scientific material. It is not a constant from 4 to 37°C, and a new BHOC formulation requires its own measurements.
A defined liver-perfusate research question
A liver study should connect the input perfusate to oxygen delivery and consumption, ATP, injury markers, vascular behaviour and organ-specific function under controlled conditions. A comparison should make its carrier, temperature and flow choices explicit.
BHOC Transplant proposes controlled ex vivo work as an early development stage. Further transplantation and clinical questions require separate protocols and their own evidence.